galactonolactone has been researched along with cycloheximide in 1 studies
| Studies (galactonolactone) | Trials (galactonolactone) | Recent Studies (post-2010) (galactonolactone) | Studies (cycloheximide) | Trials (cycloheximide) | Recent Studies (post-2010) (cycloheximide) |
|---|---|---|---|---|---|
| 31 | 0 | 4 | 19,109 | 6 | 861 |
| Protein | Taxonomy | galactonolactone (IC50) | cycloheximide (IC50) |
|---|---|---|---|
| COUP transcription factor 2 isoform a | Homo sapiens (human) | 1.315 | |
| Glucose transporter | Leishmania mexicana | 0.242 | |
| Hexose transporter 1 | Plasmodium falciparum (malaria parasite P. falciparum) | 0.31 | |
| Solute carrier family 2, facilitated glucose transporter member 1 | Homo sapiens (human) | 0.228 | |
| Eukaryotic initiation factor 4A-I | Homo sapiens (human) | 0.139 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 3.6 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 0.036 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 0.036 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lipkind, M; Shihmanter, E | 1 |
1 other study(ies) available for galactonolactone and cycloheximide
| Article | Year |
|---|---|
Effect of inhibitors of proteases and glycosidases on functional lability of newly synthesized hemagglutinin-neuraminidase glycoprotein in avirulent NDV strain-infected cells.
Topics: Animals; Cells, Cultured; Chick Embryo; Cycloheximide; Deoxyglucose; Glycoside Hydrolases; Glycosylation; Hemagglutinins, Viral; HN Protein; Neuraminidase; Newcastle disease virus; Protease Inhibitors; Sugar Acids; Tosyllysine Chloromethyl Ketone; Viral Envelope Proteins | 1987 |